Theriva Biologics Inc.

AMEX: TOVX · Real-Time Price · USD
0.49
-0.02 (-3.54%)
At close: Jul 24, 2025, 3:59 PM

Theriva Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.61M 23.18M 41.79M 67.33M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 99K n/a
Other Long-Term Assets
171K 180K -3.15M 23K
Receivables
3.32M 1.94M 231K n/a
Inventory
n/a n/a -231K n/a
Other Current Assets
235K 180K n/a n/a
Total Current Assets
16.28M 27.4M 45.52M 68.86M
Property-Plant & Equipment
1.54M 2.18M 1.54M 1.48M
Goodwill & Intangibles
17.36M 25.45M 24.68M n/a
Total Long-Term Assets
19.07M 27.82M 26.34M 1.51M
Total Assets
35.35M 55.22M 71.86M 70.36M
Account Payables
859K 770K 915K 524K
Deferred Revenue
n/a 2.87M n/a n/a
Short-Term Debt
600K 63K 273K n/a
Other Current Liabilities
4.98M 3.9M 4.25M 1.93M
Total Current Liabilities
7.58M 6.74M 7.06M 3.55M
Long-Term Debt
92K 162K 221K n/a
Other Long-Term Liabilities
6.97M 7.18M 7.21M n/a
Total Long-Term Liabilities
8.7M 8.78M 10.24M 1.4M
Total Liabilities
16.29M 15.52M 17.3M 4.96M
Total Debt
1.56M 2.15M 1.68M 1.53M
Book Value
n/a n/a n/a n/a
Book Value Per Share
n/a n/a n/a n/a
Common Stock
3K 18K 16K 132K
Retained Earnings
-334.97M -309.32M -290.97M -271.28M
Comprehensive Income
-1.18M 32K -679K n/a
Shareholders Equity
19.07M 39.7M 54.56M 65.41M
Total Investments
n/a 102K 99K n/a